HIV Vaccine :: GeoVax comments on Merck’s HIV vaccine trial

Merck & Co., Inc. announced their candidate AIDS vaccine failed to provide protection in a human study designed to test for efficacy. In this Merck trial involving high risk volunteers, an equal number of people received either placebo or AIDS vaccine. The independent Data Safety Monitoring Board recommended that the trial be stopped because it was not reaching its efficacy endpoints.

Cancer :: Increasing elderly population poses huge challenges in cancer care

Huge challenges face healthcare professionals and policy makers in planning for, and providing cancer care over the next decade or so. Chief amongst these will be ensuring that healthcare professionals have the skills and knowledge to treat a greater number of elderly people with cancer, that current inappropriate ageist attitudes towards the elderly cease, and that advances are made in ensuring that cancer patients are able to comply with their treatment.

MRI :: European directive will halt use of MRI scans

Implementation of the Physical Agents (Electromagnetic Fields) Directive 2004/40/EC in all Member States could effectively halt the use of magnetic resonance imaging (MRI), an important tool in cancer diagnosis, treatment, and research, a scientist told a press conference at the European Cancer Conference (ECCO 14) today (Monday September 24). The Directive is due to be implemented across Europe by April 2008.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack